BioCrossroads Announces 2024 FrameWORX Series Beginning March 13

BioCrossroads is thrilled to announce the 2024 lineup of FrameWORX events. This year, each event will highlight a key component of the recently released Strategic Roadmap for Advancing Indiana Life Sciences.

Released in early January 2024, the Strategy was crafted in collaboration with TEConomy Partners and provides a framework for transforming Indiana’s life sciences landscape, focusing on four pivotal areas:

  • Fostering research and development and innovation
  • Enhancing the state’s life sciences manufacturing ecosystem
  • Boosting Indiana’s life sciences talent and workforce
  • Supporting connections and outreach across the sector

The first FrameWORX of 2024 is Igniting an Industry: Indiana’s Life Sciences Strategy and will take place on March 13 at 3:30 p.m., with networking from 4:30-5:30 p.m.

Additional 2024 FrameWORX events:

May 8 – Innovating Across Indiana: The Strengths of Our Regional Life Sciences Hubs

June 20 – From Development to Delivery: Indiana’s Edge in Life Sciences Manufacturing

September 18 – Fueling the Future: Indiana’s Life Sciences Workforce

December 4 – Nuclear Medicine: Indiana’s Future in Life Sciences

All FrameWORX will take place at the Indiana Biosciences Research Institute (IBRI) at 16 Tech. These events are open to the public and there is no cost to attend, although registration is required for each date.

FrameWORX was established by BioCrossroads as an educational and networking platform to fuel growth, learning, and connectivity within Indiana’s thriving life sciences ecosystem. These events provide a hub for engaging thought leaders, offering diverse viewpoints, and fostering enhanced collaboration among the state’s research institutions, philanthropic organizations, and enterprises.

Register Here for the March 13 FrameWORX

Sign up for the BioCrossroads monthly newsletter to receive industry updates and news delivered directly to your inbox.

2024-02-14T11:23:42-05:0002/09/24|Blog, Indiana Industry News, newsroom|

Share This Story, Choose Your Platform!

Go to Top